Z

ZYME

Zymeworks Inc.
HealthcareBiotechnology|NASDAQ Global Select|CA

Price

$25.80

Market Cap

$1.92B

Beta

1.28

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+38.87%
EPS Growth (YoY)+32.92%
Revenue CAGR 3Y-36.43%
P/E Ratio0.0
PEG Ratio
FCF Yield-1.82%
Debt / Equity0.07
Interest Coverage999.0x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for ZYME.

ZYME — Zymeworks Inc. Stock Analysis | Tessera Alpha